查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
药品合约销售组织市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按服务、模组、治疗领域、最终用户和地理位置
市场调查报告书
商品编码
1372553

药品合约销售组织市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按服务、模组、治疗领域、最终用户和地理位置

Pharmaceutical Contract Sales Organizations Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services, Modules, Therapeutic Area, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 221 Pages | 订单完成后即时交付

价格

药品合约销售机构市场规模预计将从2022年的82.12亿美元成长到2030年的158.20亿美元；预计2022年至2030年复合年增长率为8.6%。

药品合约销售组织市场的成长归因于数位技术的日益融合以及製药公司对增加产品销售的兴趣日益浓厚。

远距医疗和远距详细资讯的日益普及为药品合约销售组织 (CSO) 市场带来了新的机会。数位健康科技的变革性影响重新定义了医病互动，并彻底改变了药品销售的动态。远距医疗具有促进虚拟咨询和参与的能力，为公民社会组织的适应和创新创造了肥沃的土壤。远端详细资讯涉及使用数位管道传达产品资讯并吸引医疗保健专业人员，成为公民社会组织扩大影响范围的策略途径。这项策略变化凸显了製药业为应对市场复杂性所采取的积极主动的方法。透过与公民社会组织合作，这些企业可以接触到专业销售人员，利用外部专业知识来提高市场渗透率并提高销售效率。透过这种协作模式，製药公司可以简化其营运并专注于研发等关键能力，同时利用公民社会组织的特定知识来提高其产品的适销性。製药公司和民间社会组织之间不断加强的合作表明了对适应的奉献精神以及对竞争激烈的製药行业发展动态的深刻把握。它也显示了对资源优化的细緻入微的理解。这种互惠互利的合作关係使收入最大化成为可能，并从战略上将製药公司置于适应性和针对性强的市场策略对于长期成功至关重要的市场中。

基于最终用户的见解

根据最终用户，药品合约销售组织市场分为生物製药公司和製药公司。到 2022 年，製药公司细分市场将占据更大的市场份额。製药公司是合约销售组织 (CSO) 的主要最终用户。这些公司利用公民社会组织作为策略合作伙伴，以加强其销售和行销工作、简化市场准入并优化资源配置。

由于全球新小分子药物上市数量不断增加、大量製药公司提供类似产品以及公司大量采用新技术进行合约销售，製药公司越来越多地转向 CSO 服务。此外，为製药公司招募和留住高效的销售专业人员也具有挑战性；这支持了製药公司对 CSO 服务的需求。製药公司越来越多地寻求公民社会组织帮助他们快速建立强大的销售团队，降低销售团队的管理成本，节省招募过程中的时间和精力，并发展兼职合约销售团队以消除投资需求。因此，製药公司越来越注重节省金钱和时间，这增加了药品合约销售组织市场的销售机会。

然而，预计生物製药公司细分市场在 2022 年至 2030 年期间将实现更高的复合年增长率。生物製药公司策略性地聘用公民社会组织来优化其营运的各个方面。这些合作关係有助于促进生物製药公司的销售和行销活动。 CSO 提供一群经验丰富的生物製药产品销售代表，从而实现全面的产品推广和市场渗透。它们还可以根据需要灵活地扩展销售工作，而无需内部团队的长期财务承诺。此类合作为生物製药公司提供专业知识、可扩展性和成本效率，使他们能够专注于创新和研究，同时利用公民社会组织为成功产品商业化提供的专业技能和资源。

生物製药公司正致力于提高其研究能力。根据製药研发年度回顾，2022年，在研药物总数中超过45%是生物製药。由于生物製药公司对研究和促进生物製药和小分子药物销售的高度兴趣，预计这些公司将把销售活动外包给公民社会组织，以专注于他们的研究能力，这反过来又有望支持该细分市场的市场成长。

欧洲是市场第二大主导地区。随着慢性病盛行率的快速上升、老年人口的不断增加，以及各种治疗应用对新药物分子的需求不断增加，以满足未满足的需求，该地区对药品的需求正在显着增长。近 550 家製药公司在德国开展业务。该国的合约销售组织（CSO）为大型製药公司和小型生物技术公司提供服务，帮助他们在欧洲市场取得领先地位。根据德国贸易投资总署的资料，2020年德国药品销售额较2019年成长6.7%，达607.9亿美元（495亿欧元）。

比利时的主要製药公司包括杨森製药、索尔维、UCB (Union Chimique Belge) 和 GMED Healthcare，以及巴斯夫安特卫普和葛兰素史克生物製品等子公司。此外，大多数领先的跨国公司——包括辉瑞、赛诺菲-安万特、诺华、葛兰素史克和阿斯特捷利康——在西班牙都有直接业务。这些製药巨头的存在增强了欧洲製药市场的实力。市场参与者采取的销售成长策略预计将推动该地区的药品合约销售组织市场。 CSO 帮助新兴製药公司实现品牌成功并确保财务生存能力。他们在市场分析和目标分析等领域的专业知识帮助製药公司超越目标。公民社会组织利用资料分析工具收集市场洞察、追踪产品绩效并发现机会。这种数据驱动的方法可以实现更有针对性的行销和销售工作。他们使用机器学习和人工智慧演算法来分析资料、预测销售趋势并个人化行销内容。因此，由于顶级製药公司的存在、製药公司与公民社会组织的合作以及市场参与者扩大影响力的战略努力，製药和生物製药行业的激增推动了欧洲药品合约销售组织市场的成长。

德国贸易投资总署、GLOBOCAN、疾病管制与预防中心 (CDC) 和世界卫生组织 (WHO) 是在准备药品合约销售组织市场报告时参考的主要和次要来源。

目录

第 1 章：简介

  • 研究范围
  • 市场定义、假设与限制
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：药品合约销售组织市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：药品合约销售组织市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章： 药品合约销售组织市场 - 全球市场分析

  • 药品合约销售组织 - 全球市场概览
  • 药品合约销售组织 - 全球市场和 2030 年预测

第 7 章：药品合约销售组织市场 - 收入分析 - 按服务分类，2020-2030 年

  • 概述
  • 商业服务
  • 非商业服务

第 8 章：药品合约销售组织市场 - 收入分析 - 按模组，2020-2030 年

  • 概述
  • 联合模组
  • 专用模组

第 9 章：药品合约销售组织市场 - 收入分析 - 按治疗领域，2020-2030 年

  • 概述
  • 心血管疾病
  • 肿瘤学
  • 代谢紊乱
  • 神经病学
  • 骨科疾病
  • 传染性疾病
  • 其他的

第 10 章：药品合约销售组织市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 生物製药公司
  • 製药公司

第 11 章：药品合约销售组织市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第13章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 14 章：药品合约销售组织市场 - 主要公司概况

  • CMIC Holdings Co., Ltd.

注意 - 将为以下公司列表提供类似信息

  • 阿克塞鲁斯
  • EPS 控股公司
  • 马比科
  • IQVIA 公司
  • 匹克製药
  • QFR 解决方案
  • 促进健康
  • 赛尼奥斯健康公司
  • Mednext 製药兵。有限公司

第 15 章：附录

  • 词彙表
  • 关于 Insight Partners
  • 市场情报云
Product Code: TIPRE00030074

The pharmaceutical contract sales organizations market size is expected to grow from US$ 8.212 billion in 2022 to US$ 15.820 billion by 2030; it is estimated to record a CAGR of 8.6% during 2022 to 2030.

The pharmaceutical contract sales organizations market growth is attributed to the increasing integration of digital technologies and the growing interest of pharmaceutical companies to increase sales of products.

The increasing use of telemedicine and remote detailing leads to new opportunities for the pharmaceutical contract sales organizations (CSO) market. The transformative influence of digital health technologies has redefined patient-doctor interactions and revolutionized the dynamics of pharmaceutical sales. With its capacity to facilitate virtual consultations and engagements, telemedicine creates a fertile ground for CSOs to adapt and innovate. Remote detailing, which involves using digital channels to communicate product information and engage healthcare professionals, becomes a strategic avenue for CSOs to extend their reach. This strategic change highlights the pharmaceutical industry's proactive approach to navigating the market's complexity. By working with CSOs, these businesses can access specialist sales personnel, leveraging outside expertise to increase market penetration and improve sales effectiveness. Through this collaborative model, pharmaceutical companies may streamline their operations and concentrate on key capabilities like research and development while utilizing the specific knowledge of CSOs to increase the marketability of their products. The rising cooperation between pharmaceutical corporations and CSOs demonstrates a dedication to adaptation and a profound grasp of the developing dynamics within the very competitive pharmaceutical industry. It also displays a nuanced understanding of resource optimization. This mutually beneficial partnership makes revenue maximization possible and strategically places pharmaceutical firms in a market where adaptability and focused market strategies are essential for long-term success.

End User-Based Insights

Based on end user, the pharmaceutical contract sales organizations market is segmented into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger market share in 2022. Pharmaceutical companies are the major end users of contract sales organizations (CSOs). These companies utilize CSOs as strategic partners to bolster their sales and marketing endeavors, streamline market access, and optimize resource allocation.

Pharmaceutical companies are increasingly turning to CSO services due to the growing number of new small molecule drug launches worldwide, the presence of a significant number of pharmaceutical companies offering similar products, and the high adoption of new technologies for contract sales by companies. Moreover, recruiting and retaining efficient sales professionals for pharmaceutical companies is challenging; this supports the demand for CSO services for pharmaceutical companies. Pharmaceutical companies are increasingly looking to CSOs to help them build strong sales teams quickly, reduce sales team overhead costs, save time and effort on the recruitment process, and develop part-time contract sales teams to eliminate the need for investments. Thus, the growing focus of pharmaceutical companies on saving money and time is boosting sales opportunities for the pharmaceutical contract sales organizations market.

However, the biopharmaceutical companies segment is anticipated to register a higher CAGR during 2022-2030. Biopharmaceutical companies strategically employ CSOs to optimize various facets of their operations. These partnerships are instrumental in bolstering the sales and marketing activities of biopharmaceutical companies. CSOs provide a roster of experienced sales representatives specializing in biopharmaceutical products, enabling comprehensive product promotion and market penetration. They also provide the agility to scale sales efforts as needed without the long-term financial commitment of an in-house team. Such collaborations offer biopharmaceutical companies expertise, scalability, and cost efficiencies, allowing them to focus on innovation and research while leveraging the specialized skills and resources that CSOs provide for successful product commercialization.

Biopharmaceutical companies are focusing on improving their research capabilities. According to the Pharma R&D annual review, in 2022, more than 45% of the total drugs in the pipeline were biopharmaceuticals. Owing to the high interest of biopharmaceutical companies in research and boosting the sales of biopharmaceutical and small molecule drugs, it is expected that these companies will outsource their sales activities to CSOs in order to focus on their research capabilities, which in turn is anticipated to support the market growth for the segment.

Europe is the second leading region in the market. The demand for pharmaceutical products is growing significantly in this region with the burgeoning prevalence of chronic diseases, the rising geriatric population, and increasing demand for new drug molecules for various therapeutic applications to fulfill unmet needs. Nearly 550 pharmaceutical companies have operations in Germany. Contract sales organizations (CSOs) in this country provide their services to large pharmaceutical companies and small-scale biotech companies, assisting them in attaining leading positions in the European market. As per data by Germany Trade & Invest, pharmaceutical sales in Germany increased by 6.7% in 2020 compared to 2019, reaching US$ 60.79 billion (EUR 49.5 billion).

Major pharmaceutical companies in Belgium include Janssen Pharmaceutica, Solvay, UCB (Union Chimique Belge), and GMED Healthcare, as well as subsidiaries such as BASF Antwerpen and GlaxoSmithKline Biologicals. Further, most leading multinationals-including Pfizer, Sanofi-Aventis, Novartis, GlaxoSmithKline, and AstraZeneca-have a direct presence in Spain. The presence of such pharmaceutical giants has strengthened the European pharmaceutical market. Sales growth strategies adopted by market players are anticipated to drive the pharmaceutical contract sales organizations market in the region. CSO helps attain brand success and secure the financial viability of an emerging pharmaceutical company. Their expertise in areas such as market analysis and targeting analysis helps pharmaceutical companies surpass their target goals. CSOs leverage data analytics tools to gather market insights, track product performance, and identify opportunities. This data-driven approach allows for more targeted marketing and sales efforts. They use machine learning and AI algorithms to analyze data, predict sales trends, and personalize marketing content. Therefore, the proliferating pharmaceutical and biopharmaceutical industries, owing to the presence of top pharmaceutical companies, collaborations of pharmaceutical companies with CSOs, and the strategic efforts of market players to enhance their reach, fuel the growth of the pharmaceutical contract sales organizations market in Europe.

Germany Trade & Invest, GLOBOCAN, the Centers for Disease Control and Prevention (CDC), and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the pharmaceutical contract sales organizations market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the pharmaceutical contract sales organizations market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical contract sales organizations market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Pharmaceutical Contract Sales Organizations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Pharmaceutical Contract Sales Organizations Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Pharmaceutical Contract Sales Organizations Market - Global Market Analysis

  • 6.1 Pharmaceutical Contract Sales Organizations - Global Market Overview
  • 6.2 Pharmaceutical Contract Sales Organizations - Global Market and Forecast to 2030

7. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million) - By Services, 2020-2030

  • 7.1 Overview
  • 7.2 Commercial Services
  • 7.3 Non-Commercial Services

8. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million) - By Module, 2020-2030

  • 8.1 Overview
  • 8.2 Syndicated Modules
  • 8.3 Dedicated Modules

9. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million) - By Therapeutic Area, 2020-2030

  • 9.1 Overview
  • 9.2 Cardiovascular Disorders
  • 9.3 Oncology
  • 9.4 Metabolic Disorders
  • 9.5 Neurology
  • 9.6 Orthopedic Diseases
  • 9.7 Infectious Diseases
  • 9.8 Others

10. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 10.1 Overview
  • 10.2 Biopharmaceutical Companies
  • 10.3 Pharmaceutical Companies

11. Pharmaceutical Contract Sales Organizations Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Pharmaceutical Contract Sales Organizations Market Overview
    • 11.1.2 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts to 2030
    • 11.1.3 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Services
    • 11.1.4 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Module
    • 11.1.5 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Therapeutic Area
    • 11.1.6 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Pharmaceutical Contract Sales Organizations Market
        • 11.1.7.1.1 United States Pharmaceutical Contract Sales Organizations Market, by Services
        • 11.1.7.1.2 United States Pharmaceutical Contract Sales Organizations Market, by Module
        • 11.1.7.1.3 United States Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area
        • 11.1.7.1.4 United States Pharmaceutical Contract Sales Organizations Market, by End User
      • 11.1.7.2 Canada Pharmaceutical Contract Sales Organizations Market
        • 11.1.7.2.1 Canada Pharmaceutical Contract Sales Organizations Market, by Services
        • 11.1.7.2.2 Canada Pharmaceutical Contract Sales Organizations Market, by Module
        • 11.1.7.2.3 Canada Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area
        • 11.1.7.2.4 Canada Pharmaceutical Contract Sales Organizations Market, by End User
      • 11.1.7.3 Mexico Pharmaceutical Contract Sales Organizations Market
        • 11.1.7.3.1 Mexico Pharmaceutical Contract Sales Organizations Market, by Services
        • 11.1.7.3.2 Mexico Pharmaceutical Contract Sales Organizations Market, by Module
        • 11.1.7.3.3 Mexico Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area
        • 11.1.7.3.4 Mexico Pharmaceutical Contract Sales Organizations Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Pharmaceutical Contract Sales Organizations Market - Key Company Profiles

  • 14.1 CMIC Holdings Co., Ltd.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 Axxelus
  • 14.3 EPS Holdings, Inc.
  • 14.4 MaBico
  • 14.5 IQVIA, Inc.
  • 14.6 Peak Pharma
  • 14.7 QFR Solutions
  • 14.8 Promoveo Health
  • 14.9 Syneous Health Inc.
  • 14.10 Mednext Pharmaceuticals Pvt. Ltd

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud

List Of Tables

  • Table 1. Pharmaceutical Contract Sales Organizations Market Segmentation
  • Table 4. North America Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. North America Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. North America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. North America Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. US Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. US Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. US Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. US Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Canada Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Canada Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Canada Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Canada Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Canada Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Canada Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Mexico Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Mexico Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Mexico Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Mexico Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Mexico Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Mexico Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Europe Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Europe Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Europe Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. UK Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. UK Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. UK Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. UK Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. UK Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Germany Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Germany Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Germany Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Germany Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Germany Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Germany Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. France Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. France Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. France Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. France Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. France Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. France Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. Italy Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Italy Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Italy Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Italy Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Italy Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Italy Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Spain Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Spain Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Spain Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Spain Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. Spain Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. Spain Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Rest of Europe Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Europe Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. China Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. China Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. China Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. China Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. China Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. China Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Japan Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Japan Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Japan Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Japan Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Japan Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Japan Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. India Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. India Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. India Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. India Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. India Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. India Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Australia Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Australia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. Australia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. Australia Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. Australia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. Australia Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. South Korea Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. South Korea Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. South Korea Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 | (US$ Million)
  • Table 103. South Korea Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. South Korea Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. South Korea Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 113. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 114. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 115. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 116. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 117. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 118. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 119. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 120. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 121. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 122. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 123. Saudi Arabia Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 124. UAE Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 125. UAE Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 126. UAE Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 127. UAE Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 128. UAE Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 129. UAE Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 130. South Africa Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 131. South Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 132. South Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 133. South Africa Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 134. South Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 135. South Africa Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 136. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 137. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 138. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 139. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 140. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 141. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 142. South & Central America Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 143. South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 144. South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 145. South & Central America Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 146. South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 147. South & Central America Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 148. Brazil Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 149. Brazil Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 150. Brazil Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 151. Brazil Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 152. Brazil Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 153. Brazil Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 154. Argentina Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 155. Argentina Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 156. Argentina Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 157. Argentina Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 158. Argentina Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 159. Argentina Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 160. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 161. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 162. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , For Non-Commercial Services by Services - Revenue and Forecast to 2030 (US$ Million)
  • Table 163. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Module - Revenue and Forecast to 2030 (US$ Million)
  • Table 164. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
  • Table 165. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market , by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 166. Recent Organic Growth Strategies in Pharmaceutical Contract Sales Organizations Market
  • Table 167. Recent Inorganic Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
  • Table 168. Glossary of Terms, Pharmaceutical Contract Sales Organizations Market

List Of Figures

  • Figure 1. Pharmaceutical Contract Sales Organizations Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Pharmaceutical Contract Sales Organizations Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 8. Reagents and Assay Kits: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Instruments: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Module 2022 & 2030 (%)
  • Figure 11. Tandem Mass Spectrometry (TMS): Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Molecular Assays: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Immunoassays and Enzymatic Assays: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Pulse Oximetry Screening Technology: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Other Technologies: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area 2022 & 2030 (%)
  • Figure 17. Dry Blood Spot Test: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Hearing Screen Test: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Critical Congenital Heart Diseases (CCHD) Test: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Other Test Types: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 22. Hospitals and Clinics: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Diagnostic Laboratories: Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Pharmaceutical Contract Sales Organizations Market , by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. North America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Canada Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Mexico Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Europe Pharmaceutical Contract Sales Organizations Market , by Key Country - Revenue, 2022 (US$ Million)
  • Figure 31. Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
  • Figure 33. UK Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Germany Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. France Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Italy Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Spain Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Rest of Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Asia Pacific Pharmaceutical Contract Sales Organizations Market , by Key Country - Revenue, 2022 (US$ Million)
  • Figure 40. Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Asia Pacific Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
  • Figure 42. China Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. India Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , by Key Country - Revenue, 2022 (US$ Million)
  • Figure 49. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Middle East & Africa Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. UAE Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. South Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. Rest of Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. South & Central America Pharmaceutical Contract Sales Organizations Market , by Key Country - Revenue, 2022 (US$ Million)
  • Figure 56. South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. South & Central America Pharmaceutical Contract Sales Organizations Market , By Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. Argentina Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Rest of South & Central America Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Growth Strategies in Pharmaceutical Contract Sales Organizations Market